PMID: 11337152May 5, 2001Paper

Enhanced plasmid DNA transfection with lysosomotropic agents in cultured fibroblasts

International Journal of Pharmaceutics
K Ciftci, R J Levy

Abstract

Transfer of plasmid DNA into mammalian cells has posed major challenges for gene therapy. Most non-viral vectors are known to internalize in the cells by endocytosis. Therefore, low transfection efficiency of non-viral vectors may be due to intracellular degradation of input DNA in the endosomes and/or lysosomes. DNA degradation can be inhibited either by inactivating the lysosomal enzymes or obliterating endosome fusion to lysosomes using lysosomotropic agents. We report here the effects of individual lysosomotropic agents such as chloroquine, polyvinylpyrolidone (PVP) and sucrose on beta-gal expression in cultured fibroblasts COS, 293 and CHO. Cell viability was influenced by type, exposure time and concentration of lysosomotropic agents. Exposure to chloroquine at high concentration (1000 microM) or more than 4 h at any concentration (10-1000 microM) caused extensive cell death, however, cytotoxicity due to sucrose (5-500 mM) and PVP (0.01-1 mg/ml) was minimal in the cell lines tested. All the agents utilized in this study enhanced the gene expression and the transfection efficiency followed the order of sucrose>chloroquine>PVP at the concentrations used in all cell lines. Results suggest that lysosomotropic agents can enhan...Continue Reading

References

Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·E WagnerM L Birnstiel
Apr 1, 1990·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·A E Smits-Van ProoijeE J Sinkeldam
Sep 15, 1974·Biochemical Pharmacology·C de DuveF Van Hoof
Mar 11, 1983·Nucleic Acids Research·H Luthman, G Magnusson
Jan 1, 1984·The Journal of Cell Biology·B StorrieC Oliver
Jan 1, 1984·Molecular and Cellular Biochemistry·T KatoH Yabuuchi
Mar 1, 1980·Experimental Cell Research·L OseT Berg
Feb 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J Y Legendre, F C Szoka
Jul 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·H L DavisR H Purcell
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·O Zelphati, F C Szoka
Aug 10, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·S ArmeanuS Nikol

❮ Previous
Next ❯

Citations

Sep 12, 2002·Journal of Physiology and Biochemistry·A RochaJ M Coll
Mar 11, 2005·Advanced Drug Delivery Reviews·Delphine LechardeurGergely L Lukacs
Mar 17, 2004·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Kerstin TabattClaus-Michael Lehr
Sep 3, 2002·Advanced Drug Delivery Reviews·Thomas MerdanThomas Kissel
Sep 3, 2002·Biochimica Et Biophysica Acta·Birgit NeukammChristine Lang
Oct 24, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jon A Wolff, David B Rozema
Sep 25, 2003·Human Gene Therapy·Brian A KarolewskiJohn H Wolfe
Dec 8, 2009·Biochemistry. Biokhimii︠a︡·Y S Tarahovsky
Oct 19, 2011·Orphanet Journal of Rare Diseases·Giuseppina AndreottiMaria Vittoria Cubellis
Jul 6, 2004·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Hidetoshi Arima
Sep 13, 2013·Therapeutic Delivery·Sigurd Leinæs Bøe, Eivind Hovig
Aug 30, 2007·Proceedings of the National Academy of Sciences of the United States of America·Miriam BreunigAchim Goepferich
Dec 23, 2006·Expert Review of Vaccines·Wolfgang Jechlinger
Feb 8, 2006·FEBS Letters·Takehiko Shiraishi, Peter E Nielsen
Mar 6, 2010·Expert Opinion on Drug Delivery·Rodney F Minchin, Shu Yang
Apr 18, 2013·Expert Opinion on Biological Therapy·Maria Mercedes SeguraAlain Garnier
Jan 18, 2003·Journal of Pharmaceutical Sciences·Christopher M Wiethoff, C Russell Middaugh
Aug 26, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Nian-Qiu ShiYong Zhang
Dec 3, 2014·Biochimica Et Biophysica Acta·Aqeel AhmadPaavo K J Kinnunen
Aug 10, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Eleonora VighiEliana Leo
May 26, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ayman El-SayedHideyoshi Harashima
Dec 31, 2008·Journal of Virological Methods·Hitoshi KurodaJakob Reiser
Jul 1, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tali KatavJoseph Kost
Aug 11, 2006·The Journal of Gene Medicine·Samir El-AndaloussiUlo Langel
Dec 21, 2004·International Journal of Pharmaceutics·Savita BishtAmarnath Maitra
Jun 16, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kerstin TabattUdo Bakowsky
May 26, 2004·Biochemical and Biophysical Research Communications·Nicolas J CaronJacques P Tremblay
Jan 2, 2007·International Journal of Pharmaceutics·Ali M TamaddonHamid R Moghimi
Dec 27, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Saïd AbesBernard Lebleu
Nov 18, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Nina PedersenHans S Poulsen
Nov 19, 2011·Bioengineered Bugs·Wing CheungClare Huxley
Aug 28, 2013·Biotechnology Advances·Qin ZhengYuan Wan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.